ReNewVax develops pneumococcal vaccines to prevent life-threatening bacterial infections and diseases such as pneumonia, meningitis, and sepsis. Its product pipeline includes RVX-001, a novel and cost-effective protein-based vaccine against pneumococcal invasive disease, RVX-002 Streptococcus pyogenes vaccine for invasive neonatal disease, and